Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Meglumine Antimoniate for Cutaneous Leishmaniasis in Elderly
NCT00818818Phase 4Completed
- Sponsor
- University of Brasília
- Start
- Aug 2008
- Primary completion
- Jan 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by University of Brasília. Started Aug 2008; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00818818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818818.